Structure-based drug design of phenazopyridine derivatives as inhibitors of Rev1 interactions in translesion synthesis

Rev1 is a protein scaffold of the translesion synthesis (TLS) pathway, which employs low-fidelity DNA polymerases for replication of damaged DNA. The TLS pathway helps cancers tolerate DNA damage induced by genotoxic chemotherapy, and increases mutagenesis in tumors, accelerating the onset of chemor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ChemMedChem
Hlavní autoři: McPherson, Kerry Silva, Zaino, Angela M., Dash, Radha C., Rizzo, Alessandro A., Li, Yunfeng, Hao, Bing, Bezsonova, Irina, Hadden, M. Kyle, Korzhnev, Dmitry M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035318/
https://ncbi.nlm.nih.gov/pubmed/33314657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.202000893
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky